Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

124411 Press Releases
DateTitleCompany
18 Sep 15 Cyclacel Presents Molecular Rationale for Clinical Development of CYC065 CDK Inhibitor in Leukemias and Lymphomas Cyclacel ,
Published by
Pharmiweb.com
18 Sep 15 OncoMed Presents Immuno-Oncology Data for GITRL-Fc Candidate at the Inaugural International Cancer Immunotherapy Conference OncoMed ,
Published by
Pharmiweb.com
18 Sep 15 U.S. Food and Drug Administration Grants Fast Track Designation to Can-Fite's CF102 in the Treatment of Liver Cancer Can-Fite BioPharma,
Published by
Pharmiweb.com
18 Sep 15 Inovio Pharmaceuticals Publishes Successful Phase 2b Trial Results of Its HPV Immunotherapy in The Lancet Inovio,
Published by
Pharmiweb.com
18 Sep 15 Inovio's Chief Operating Officer Selected by PharmaVoice as One of the Most Inspirational Leaders in the Global Industrysa Announces Publication of Patiromer FOS Onset-of-Action Study in Kidney International Inovio,
Published by
Pharmiweb.com
18 Sep 15 Relypsa Announces Publication of Patiromer FOS Onset-of-Action Study in Kidney International Relypsa ,
Published by
Pharmiweb.com
18 Sep 15 Apricus Reports Top-Line Phase 2a Data for RayVa(TM), Its Topical Treatment for Raynaud's Phenomenon Apricus Biosciences ,
Published by
Pharmiweb.com
18 Sep 15 Apricus Biosciences Enters Into License Agreement With Allergan for the U.S. Rights to Vitaros(TM) Apricus Biosciences ,
Published by
Pharmiweb.com
18 Sep 15 Impax Receives FDA Approval for Generic Version of Mestinon® Timespan® Tablets, 180 mg Impax ,
Published by
Pharmiweb.com
18 Sep 15 Lion Biotechnologies Announces Positive Updated Data from NCI’s Phase 2 Study of TIL Therapy in the Treatment of Metastatic Melanoma Lion Biotechnologies ,
Published by
Pharmiweb.com
18 Sep 15 Lion Biotechnologies Opens Enrollment in Phase 2 Study of LN-144 for the Treatment of Refractory Metastatic Melanoma Lion Biotechnologies ,
Published by
Pharmiweb.com
18 Sep 15 ZIOPHARM Announces Presentation of Clinical and Preclinical Data From Ad-RTS-IL-12 at CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference Published by
GlobeNewswire
18 Sep 15 BioMarin Announces Kuvan(R) (sapropterin dihydrochloride) Patent Challenge Settlement Published by
GlobeNewswire
18 Sep 15 New Treatment Options for Carbapenem-Resistant Enterobacteriaceae (CRE) Infection Needed, According to Study by The Medicines Company The Medicines Company,
Published by
Business Wire
18 Sep 15 The Medicines Company Reports Discovery of New Series of Beta-Lactamase Inhibitors at ICAAC/ICC 2015 The Medicines Company,
Published by
Business Wire
18 Sep 15 Matinas BioPharma's MAT2203 -- Encochleated Formulation of Amphotericin B -- Shows Potential to Target and Penetrate Tissue Infected With Invasive Candidiasis in Data Presented at ICAAC/ICC 2015 Published by
GlobeNewswire
18 Sep 15 AMCP Partnership Forum Identifies Strategies for Better Cholesterol Management in Light of New PCSK9 Inhibitors Academy of Managed Care Pharmacy,
Published by
PR Newswire
18 Sep 15 TAXIS Pharmaceuticals Demonstrates Synergistic Efficacy Against MRSA And Low Resistance Frequency With TXA709/Cefdinir Combination TAXIS Pharmaceuticals,
Published by
PR Newswire
18 Sep 15 Horizon Discovery Group plc Enters Bioproduction Cell Line Licensing Agreement with LakePharma, Inc. Horizon Discovery Group plc ,
Published by
Pharmiweb.com
18 Sep 15 Aquinox Presents at 2015 International Society for the Study of BPS Conference Published by
GlobeNewswire
18 Sep 15 CIRCA Scientific Announces Agreement with MAGNET Group for Company's Esophageal Temperature Monitoring System CIRCA Scientific,
Published by
PR Newswire
18 Sep 15 Results of Phase 2 Study of Merck’s Investigational Beta-Lactamase Inhibitor Relebactam Presented at ICAAC/ICC 2015 Merck,
Published by
Business Wire
18 Sep 15 AmpliPhi Announces Data Demonstrating Efficacy of a Novel Bacteriophage Cocktail is Comparable to Vancomycin in S. aureus Lung Infection Model AmpliPhi Biosciences Corporation,
Published by
Business Wire
18 Sep 15 Cystic Fibrosis Foundation Provides Expert Testimony to Congress in Support of the Ensuring Access to Clinical Trials Act Cystic Fibrosis Foundation,
Published by
Business Wire
18 Sep 15 MDxHealth(R): Completion of the acquisition of NovioGendix - New share capital amount and new number of shares Published by
GlobeNewswire
18 Sep 15 Harbour Antibodies Announces 25th License to Its Transgenic Mouse Platforms for Next Generation Monoclonal Antibody Discovery Harbour Antibodies BV,
Published by
Business Wire
18 Sep 15 Biothera’s Imprime PGG Cancer Immunotherapy Drug Activates Dendritic Cells, Leading to Enhanced T Cell Expansion and Cytokine Production Biothera Pharmaceutical Inc.,
Published by
Business Wire
18 Sep 15 Biothera’s Cancer Immunotherapy Drug Imprime PGG Elicits Increased Natural Killer Cell Activation and Cancer Cell Killing Biothera,
Published by
Business Wire
18 Sep 15 Pharmaceutical Strategies Group to Detail How to Better Control Pharmacy Benefit, Specialty Drug Costs at ASHHRA Conference Pharmaceutical Strategies Group,
Published by
Business Wire
18 Sep 15 Pharma-logistics has head in sand FlyPharma,
Published by
Capitol Marcomms
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.